Mechanisms of growth inhibition in keratinocytes by mercurio-substituted 4',5'-dihydropsoralens.

[1]  R. Stern.  The risk of melanoma in association with long-term exposure to PUVA. , 2001, Journal of the American Academy of Dermatology.

[2]  G. Stark,et al.  Regulation of the G2/M transition by p53 , 2001, Oncogene.

[3]  D. Coradini,et al.  Sodium butyrate modulates cell cycle‐related proteins in HT29 human colonic adenocarcinoma cells , 2000, Cell proliferation.

[4]  F. Gasparro,et al.  Psoralen photobiology and photochemotherapy: 50 years of science and medicine. , 1999, Journal of dermatological science.

[5]  B. Kamen.  Folate and antifolate pharmacology. , 1997, Seminars in oncology.

[6]  D. Heck,et al.  Arginine metabolism in keratinocytes and macrophages during nitric oxide biosynthesis: multiple modes of action of nitric oxide synthase inhibitors. , 1997, Biochemical pharmacology.

[7]  J. Vera,et al.  Efficient Transport and Accumulation of Vitamin C in HL-60 Cells Depleted of Glutathione* , 1997, The Journal of Biological Chemistry.

[8]  D. W. Gruenwedel,et al.  Effect of Hg(II) on d(GCGCATATGCGC)2 conformation: UV absorption and circular dichroism studies. , 1993, Journal of inorganic biochemistry.

[9]  D. Laskin,et al.  Epidermal growth factor suppresses nitric oxide and hydrogen peroxide production by keratinocytes. Potential role for nitric oxide in the regulation of wound healing. , 1992, The Journal of biological chemistry.

[10]  J. Laskin,et al.  Inhibition of epidermal growth factor receptor tyrosine kinase activity in A431 human epidermoid cells following psoralen/ultraviolet light treatment. , 1989, Molecular pharmacology.

[11]  J. Laskin,et al.  Characterization of a photoalkylated psoralen receptor in HeLa cells. , 1987, The Journal of biological chemistry.

[12]  M. Gallo,et al.  A possible mechanism of psoralen phototoxicity not involving direct interaction with DNA. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[13]  F. Dall'acqua,et al.  Methylangelicins: new potential agents for the photochemotherapy of psoriasis. Structure-activity study on the dark and photochemical interactions with DNA. , 1981, Journal of medicinal chemistry.

[14]  P. Song,et al.  PHOTOCHEMISTRY AND PHOTOBIOLOGY OF PSORALENS , 1979, Photochemistry and photobiology.

[15]  E. Cafruny.  The site and mechanism of action of mercurial diruetics. , 1968, Pharmacological reviews.

[16]  G. Mudge,et al.  Studies on mercurial diureis: renal excretion, acid stability and structure-activity relationships of organic mercurials. , 1962, The Journal of pharmacology and experimental therapeutics.

[17]  O. Muller,et al.  A polarographic study of mersalyl (salyrgan)-thiol complexes and of the excreted products of mersalyl. , 1955, The Journal of pharmacology and experimental therapeutics.

[18]  J. Laskin,et al.  Mechanism of action of psoralens: isobologram analysis reveals that ultraviolet light potentiation of psoralen action is not additive but synergistic , 2004, Cancer Chemotherapy and Pharmacology.

[19]  A. Vetrano,et al.  Cell-impermeant pyridinium derivatives of psoralens as inhibitors of keratinocyte growth. , 2002, Biochemical pharmacology.

[20]  F. Gasparro,et al.  Psoralen photobiology: the relationship between DNA damage, chromatin structure, transcription, and immunogenic effects. , 1997, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[21]  F. Dall'acqua,et al.  Psoralen photosensitization: damages to nucleic acid and membrane lipid components. , 1996, Acta biochimica Polonica.

[22]  J. Laskin,et al.  Psoralen binding and inhibition of epidermal growth factor binding by psoralen/ultraviolet light (PUVA) in human epithelial cells. , 1991, Biochemical pharmacology.

[23]  J. Laskin,et al.  Novel syntheses of dihydroxanthyletin and dihydroseselin derivatives , 1990 .

[24]  F. Dall'acqua,et al.  Present aspects concerning the molecular mechanisms of photochemotherapy with psoralens. , 1986, Drugs under experimental and clinical research.

[25]  Thomas B. Fitzpatrick,et al.  Photochemotherapy of Skin Diseases , 1982 .

[26]  John A. Parrish,et al.  The Science of Photomedicine , 1982, Photobiology.